• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000年至2012年医疗保险人群住院经皮冠状动脉介入治疗后的再入院情况。

Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.

作者信息

McNeely Christian, Markwell Stephen, Vassileva Christina M

机构信息

Southern Illinois University School of Medicine, Department of Surgery, Division of Cardiothoracic Surgery, Springfield, IL.

Southern Illinois University School of Medicine, Department of Surgery, Division of Cardiothoracic Surgery, Springfield, IL.

出版信息

Am Heart J. 2016 Sep;179:195-203. doi: 10.1016/j.ahj.2016.07.002. Epub 2016 Jul 14.

DOI:10.1016/j.ahj.2016.07.002
PMID:27595697
Abstract

BACKGROUND

Since year 2000, reducing hospital readmissions has become a public health priority. In addition, there have been major changes in percutaneous coronary intervention (PCI) during this period.

METHODS

The cohort consisted of 3,250,194 patients admitted for PCI from January 2000 through November 2012.

RESULTS

Overall, 30-day readmission was 15.8%. Readmission rates declined from 16.1% in 2000 to 15.4% in 2012 (adjusted odds ratio for readmission 1.33 in 2000 compared with 2012). Of all readmissions after PCI, the majority were for cardiovascular-related conditions (>60%); however, only a small percentage (<8%) of total readmissions were for acute myocardial infarction, unstable angina, or cardiac arrest/cardiogenic shock. A much larger percentage of patients were readmitted with chest pain/angina (7.9%), chronic ischemic heart disease (26.6%), and heart failure (12%). A small proportion was due to procedural complications and gastrointestinal (GI) bleeding. The use of PCI with stenting during readmissions was variable, increasing from 14.2% in 2000 to 23.7% in 2006 and then declining to 12.1% in 2012. Hospital mortality during readmission was 2.5% overall and varied over time (2.8% in 2000, decreasing to 2.2% in 2006 and then rising again to 3.1% in 2012). Patients who were readmitted had >4× higher 30-day mortality than those who were not.

CONCLUSIONS

Among Medicare beneficiaries, readmission after PCI declined over time despite patients having more comorbidities. This translated into a 33% lower likelihood of readmission in 2012 compared with 2000. A small proportion of readmissions were for acute coronary syndromes.

摘要

背景

自2000年以来,降低医院再入院率已成为公共卫生的重点。此外,在此期间经皮冠状动脉介入治疗(PCI)也发生了重大变化。

方法

该队列包括2000年1月至2012年11月因PCI入院的3250194例患者。

结果

总体而言,30天再入院率为15.8%。再入院率从2000年的16.1%下降至2012年的15.4%(2000年与2012年相比,再入院的调整比值比为1.33)。在PCI后的所有再入院病例中,大多数是心血管相关疾病(>60%);然而,急性心肌梗死、不稳定型心绞痛或心脏骤停/心源性休克导致的再入院病例仅占总再入院病例的一小部分(<8%)。因胸痛/心绞痛(7.9%)、慢性缺血性心脏病(26.6%)和心力衰竭(12%)再次入院的患者比例要大得多。一小部分是由于手术并发症和胃肠道出血。再入院期间使用带支架的PCI情况各不相同,从2000年的14.2%增加到2006年的23.7%,然后在2012年降至12.1%。再入院期间的医院死亡率总体为2.5%,且随时间变化(2000年为2.8%,2006年降至2.2%,然后在2012年再次升至3.1%)。再入院患者的30天死亡率比未再入院患者高4倍以上。

结论

在医疗保险受益人中,尽管患者合并症增多,但PCI后的再入院率随时间下降。与2000年相比,2012年再入院的可能性降低了33%。一小部分再入院是由于急性冠状动脉综合征。

相似文献

1
Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.2000年至2012年医疗保险人群住院经皮冠状动脉介入治疗后的再入院情况。
Am Heart J. 2016 Sep;179:195-203. doi: 10.1016/j.ahj.2016.07.002. Epub 2016 Jul 14.
2
Causes of short-term readmission after percutaneous coronary intervention.经皮冠状动脉介入治疗后短期再入院的原因。
Circ Cardiovasc Interv. 2014 Feb;7(1):97-103. doi: 10.1161/CIRCINTERVENTIONS.113.000988. Epub 2014 Jan 14.
3
Effect of Gender on Unplanned Readmissions After Percutaneous Coronary Intervention (from the Nationwide Readmissions Database).性别对经皮冠状动脉介入治疗后非计划再入院的影响(来自全国再入院数据库)
Am J Cardiol. 2018 Apr 1;121(7):810-817. doi: 10.1016/j.amjcard.2017.12.032. Epub 2018 Jan 10.
4
Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database Analysis.美国经皮冠状动脉介入治疗后的 30 天再入院率和费用:全国再入院数据库分析。
Circ Cardiovasc Interv. 2017 Dec;10(12). doi: 10.1161/CIRCINTERVENTIONS.117.005925.
5
Factors associated with 30-day readmission rates after percutaneous coronary intervention.经皮冠状动脉介入治疗后30天再入院率的相关因素。
Arch Intern Med. 2012 Jan 23;172(2):112-7. doi: 10.1001/archinternmed.2011.569. Epub 2011 Nov 28.
6
Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.急性心肌梗死合并心源性休克患者经皮冠状动脉介入治疗后 30 天再入院率及其原因。
Catheter Cardiovasc Interv. 2019 Aug 1;94(2):E67-E77. doi: 10.1002/ccd.28161. Epub 2019 Feb 27.
7
Etiologies and predictors of 30-day readmissions in patients undergoing percutaneous mechanical circulatory support-assisted percutaneous coronary intervention in the United States: Insights from the Nationwide Readmissions Database.美国接受经皮机械循环支持辅助经皮冠状动脉介入治疗患者30天再入院的病因及预测因素:来自全国再入院数据库的见解
Clin Cardiol. 2018 Apr;41(4):450-457. doi: 10.1002/clc.22893. Epub 2018 Apr 26.
8
Thirty-day readmission rates after PCI in a metropolitan center in Europe: incidence and impact on prognosis.欧洲某大都市中心经皮冠状动脉介入治疗(PCI)后的30天再入院率:发生率及其对预后的影响。
J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):238-45. doi: 10.2459/JCM.0000000000000136.
9
All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients.一组医疗保险患者经皮冠状动脉介入治疗后的全因再入院和重复血运重建情况。
J Am Coll Cardiol. 2009 Sep 1;54(10):903-7. doi: 10.1016/j.jacc.2009.04.076.
10
Thirty-Day Readmissions After Chronic Total Occlusion Percutaneous Coronary Intervention in the United States: Insights From the Nationwide Readmissions Database.美国慢性完全闭塞经皮冠状动脉介入治疗 30 天再入院率:来自全国再入院数据库的分析。
Cardiovasc Revasc Med. 2020 Aug;21(8):992-997. doi: 10.1016/j.carrev.2019.12.025. Epub 2019 Dec 26.

引用本文的文献

1
Risk factors for 30-day unplanned readmissions after surgical procedures in the elderly population.老年人群外科手术后30天内非计划再入院的危险因素。
Patient Saf Surg. 2025 Jul 1;19(1):19. doi: 10.1186/s13037-025-00442-2.
2
Factors influencing readmission among Thais with myocardial infarction.影响泰国心肌梗死患者再入院的因素。
Belitung Nurs J. 2021 Feb 22;7(1):15-23. doi: 10.33546/bnj.1234. eCollection 2021.
3
Incidence and prognosis of late readmission after percutaneous coronary intervention.经皮冠状动脉介入治疗后晚期再入院的发生率和预后。
Cardiol J. 2023;30(5):696-704. doi: 10.5603/CJ.a2022.0117. Epub 2022 Dec 13.
4
LncRNA UCA1, miR-26a, and miR-195 in coronary heart disease patients: Correlation with stenosis degree, cholesterol levels, inflammatory cytokines, and cell adhesion molecules.冠心病患者中的长链非编码 RNA UCA1、miR-26a 和 miR-195:与狭窄程度、胆固醇水平、炎症细胞因子和细胞黏附分子的相关性。
J Clin Lab Anal. 2022 Jan;36(1):e24070. doi: 10.1002/jcla.24070. Epub 2021 Dec 1.
5
Impact of the Malnutrition on Mortality in Elderly Patients Undergoing Percutaneous Coronary Intervention.营养不良对行经皮冠状动脉介入治疗老年患者死亡率的影响。
Clin Interv Aging. 2021 Jul 14;16:1347-1356. doi: 10.2147/CIA.S308569. eCollection 2021.
6
Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy.口服抗凝治疗出院患者经皮冠状动脉介入治疗后早期再入院的原因和预测因素。
PLoS One. 2018 Oct 31;13(10):e0205457. doi: 10.1371/journal.pone.0205457. eCollection 2018.
7
Etiologies and predictors of 30-day readmissions in patients undergoing percutaneous mechanical circulatory support-assisted percutaneous coronary intervention in the United States: Insights from the Nationwide Readmissions Database.美国接受经皮机械循环支持辅助经皮冠状动脉介入治疗患者30天再入院的病因及预测因素:来自全国再入院数据库的见解
Clin Cardiol. 2018 Apr;41(4):450-457. doi: 10.1002/clc.22893. Epub 2018 Apr 26.
8
An Evaluation of the Cost-effectiveness of Comprehensive MTM Integrated with Point-of-Care Phenotypic and Genetic Testing for U.S. Elderly Patients After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后美国老年患者综合用药管理联合即时表型和基因检测的成本效果评价
J Manag Care Spec Pharm. 2018 Feb;24(2):142-152. doi: 10.18553/jmcp.2018.24.2.142.
9
Should We Care About Short-Term Readmissions After Percutaneous Coronary Intervention?经皮冠状动脉介入治疗后我们应该关注短期再入院情况吗?
Circ Cardiovasc Interv. 2017 Dec;10(12). doi: 10.1161/CIRCINTERVENTIONS.117.006123.
10
Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.阿拉巴马大学伯明翰分校的精准医学:通过实施基因分型指导的抗血小板治疗奠定基础流程
Clin Pharmacol Ther. 2017 Sep;102(3):493-501. doi: 10.1002/cpt.631. Epub 2017 Jun 1.